Stay updated on EMpagliflozin Effects on Cardiac Function in AMI - Clinical Trial
Sign up to get notified when there's something new on the EMpagliflozin Effects on Cardiac Function in AMI - Clinical Trial page.

Latest updates to the EMpagliflozin Effects on Cardiac Function in AMI - Clinical Trial page
- Check5 days agoChange DetectedLocation entries were updated to replace 'State of Salzburg' with 'Salzburg' and to format 'Schwarzach im Pongau' as 'Schwarzach im Pongau, Salzburg, Austria, 5620'; the page revision was updated to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. This appears to be a platform-level update and does not affect the study details or outcomes on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, indicating an internal update. No study content or user-facing information was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now includes a glossary toggle and updated QC-related labels and version text (No FEAR Act Data and Revision: v3.4.0), replacing previous wording. The core study content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to EMpagliflozin Effects on Cardiac Function in AMI - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMpagliflozin Effects on Cardiac Function in AMI - Clinical Trial page.